profile

T2B Monthly

Featured Post

Recap: Fighting Misinformation Without Amplifying It

Hi! At our February Comm Convo, Fighting Misinformation Without Amplifying It, we examined the practical reality biopharma communicators navigate every day: A fast-moving information environment where incomplete, misleading, or distorted claims can gain traction quickly. There is rarely a clean or standard how-to for responding when misinformation spreads. Instead, effective responses depend on preparation, cross-functional alignment, and disciplined judgment about when engagement adds...

Hi! A quick reminder that tomorrow is our inaugural PA&E Roundtable event. Wherever the patient advocacy function formally sits in an organization research, communicators are often the ones helping translate those patient insights into stories that resonate internally and externally. Tomorrow’s conversation will explore how teams gather those insights, how communicators partner across functions, and what it takes to represent patient experiences thoughtfully and responsibly in our work. The...

Hi! As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations. But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics. Our March Comm Convo brings together communicators who have worked in and out of life sciences to...

T2B Monthly | February 2026 Hi! Even though we always ask our panelists to ditch the BS, even I'm sometimes surprised by the candor that shows up. Across our Post-JPM press panel, Beyond ChatGPT webinar this morning, and Navigating Misinformation Comm Convo, this month was no exception. I also want to shout out our roundtables. Member-led, volunteer-driven, diving deep into the disciplines that make up our world. They are setting a high bar. Seriously. Someone called T2B a "movement" the...

Hi! A quick reminder about tomorrow’s Q1 AI Roundtable panel. We all love ChatGPT, but this discussion is designed to give us a broader view into the AI tools communicators should consider experimenting with right now, and how to use each with more precision. Beyond ChatGPT: The AI Toolkit Every Communicator Needs in 2026 📅 (Tomorrow) Friday, February 27th @ 12-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMTSign up here. Exclusive to T2B Pro and Student members T2B AI Roundtable members Matthew...

Hi! As an entrepreneur, I often think about "the business of the business." But in a broader sense, we communicators are expected to be commercial thinkers, financial translators, growth partners, and strategic counselors. So our first masterclass of the year starts there. The Business of the Business Masterclass Building Communications Practices That Scale🗓️ Tuesday, March 31st | Noon-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMTExclusive to T2B Pro and Student membersRegister here I’m thrilled to...

HI! Regardless of whether IR is formally in your remit, ESG conversations are showing up everywhere right now... in earnings prep, in board discussions, in analyst questions, and increasingly in conversations about patient trust. Investors are evaluating governance, capital discipline, and long-term risk. But in our industry, ESG carries a different weight because patients and advocacy communities are watching how companies show up on access, equity, and corporate responsibility. That’s what...

Hi! On the heels of JPM, T2B's Media Minds Roundtable invited Annalee Armstrong of BioSpace, Max Bayer of Endpoints, and Mandy Jackson of Scrip to discuss the issues they believe will shape the industry news environment in 2026. From regulatory uncertainty to the return of the IPO window to the rise of China, they shared their perspectives on how to separate signal from noise, and what makes a banner headline. If you weren’t able to make the discussion or want to listen again, the replay is...

Hi! We all know that patient advocacy shows up differently across organizations. Sometimes it sits within medical. Sometimes commercial. Sometimes corporate affairs. Sometimes it stands alone. Where it sits changes how we tell those stories, and how the patient voice ultimately shows up in our narratives. Our inaugural Patient Advocacy & Engagement Roundtable panel brings together leaders who have overseen advocacy from multiple vantage points, including within integrated corporate affairs...

Hi! A quick reminder about tomorrow’s Comm Convo: We're focusing on the environment we’re all navigating right now, shaped by social media dynamics, AI-generated content, fragmented audiences, and uneven trust. In this context, misinformation is part of the backdrop. The harder question is often what to do about it. When does engagement clarify? When does it extend the life of a claim? And how do we advise leaders when there’s no obvious playbook? February Comm Convo: Fighting Misinformation...